$中慧生物-B(02_老虎社区_美港股上老虎

$中慧生物-B(02627)$ 在研管线方面，冻干人用狂犬病疫苗（人二倍体细胞）进入临床冲刺阶段。该产品采用世卫组织推荐的"最安全细胞培养基质"，相较传统Vero细胞疫苗具有更高的安全性优势

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

阿福哥哥
11-04
阿福哥哥
期待有机会入场

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":494795268666144,"tweetId":"494795268666144","gmtCreate":1761813465265,"gmtModify":1761813467108,"author":{"id":4193625296607780,"idStr":"4193625296607780","authorId":4193625296607780,"authorIdStr":"4193625296607780","name":"打铁不如李铁","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 在研管线方面，冻干人用狂犬病疫苗（人二倍体细胞）进入临床冲刺阶段。该产品采用世卫组织推荐的\"最安全细胞培养基质\"，相较传统Vero细胞疫苗具有更高的安全性优势</body></html>","htmlText":"<html><head></head><body><a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 在研管线方面，冻干人用狂犬病疫苗（人二倍体细胞）进入临床冲刺阶段。该产品采用世卫组织推荐的\"最安全细胞培养基质\"，相较传统Vero细胞疫苗具有更高的安全性优势</body></html>","text":"$中慧生物-B(02627)$ 在研管线方面，冻干人用狂犬病疫苗（人二倍体细胞）进入临床冲刺阶段。该产品采用世卫组织推荐的\"最安全细胞培养基质\"，相较传统Vero细胞疫苗具有更高的安全性优势","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/494795268666144","repostId":0,"isVote":1,"tweetType":1,"viewCount":304,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02627"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":166,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":496393747927080,"commentId":"496393747927080","gmtCreate":1762213064335,"gmtModify":1762213067936,"authorId":3525842395103999,"author":{"id":3525842395103999,"idStr":"3525842395103999","authorId":3525842395103999,"name":"阿福哥哥","avatar":"https://static.tigerbbs.com/6cc6b3ae782876f9a394aed9d99d2311","vip":1,"currentWearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.06.29","exceedPercentage":"93.97%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":8,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":494795268666144,"objectIdStr":"494795268666144","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"期待有机会入场","text":"期待有机会入场","html":"期待有机会入场","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/494795268666144"}